---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-024727"
form_type: "8-K"
ticker: "TVGN"
cik: "0001860871"
company_name: "Tevogen Bio Holdings Inc."
filed_at: "2024-06-21T23:59:59+00:00"
generated_at: "2026-06-01T03:01:49.183295+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Tevogen Bio receives Nasdaq bid price deficiency notice, repurchases Series B Preferred Stock

## Summary
- Received Nasdaq letter on June 14, 2024, for non-compliance with $1.00 minimum bid price rule for 35 consecutive business days.
- Company has 180 days until December 11, 2024, to regain compliance by closing bid price at $1.00 or more for 10 consecutive days.
- Repurchased all 3,613 shares of Series B Preferred Stock from SSVK Associates LLC on June 15, 2024, reassuming $3.6 million liabilities.
- Suren Ajjarapu, managing member of SSVK, is a board member; SSVK owns over 5% of common stock.
- Repurchase cancelled all outstanding Series B Preferred Stock; related Assignment and Assumption Agreement terminated.

## SEC filing metadata
- accession: 0001493152-24-024727
- form_type: 8-K
- ticker: TVGN
- cik: 0001860871
- company_name: Tevogen Bio Holdings Inc.
- filed_at: 2024-06-21T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 1.02, 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860871/000149315224024727/0001493152-24-024727-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860871/000149315224024727/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-024727
- JSON: https://secwatch.observer/filing/0001493152-24-024727.json
- Plain text: https://secwatch.observer/filing/0001493152-24-024727.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.